ALHAMBRA, Calif., Dec. 20, 2021 /PRNewswire/ -- Apollo Medical
Holdings, Inc. ("ApolloMed," and together with its subsidiaries and
affiliated entities, the "Company") (NASDAQ: AMEH), a leading
physician-centric, technology-powered healthcare company focused on
enabling providers in the successful delivery of value-based care,
today announced the appointments of Weili
Dai, a renowned entrepreneur, technology executive and
philanthropist, and J. Lorraine Estradas, R.N., B.S.N., M.P.H., an
experienced leader in the Los
Angeles healthcare industry, to its Board of Directors,
effective December 31, 2021.
Boasting over 25 years of experience in the technology industry,
Ms. Dai is the cofounder of global semiconductor company Marvell
Technology where she served as President and Director until 2016.
In 2018, Ms. Dai cofounded MeetKai, Inc., an AI-enabled
personalized conversational search company, and continues to serve
as its Executive Chairwoman today. She also serves as Chairman of
the Board at Lark Health, a healthcare technology company aimed at
delivering scalable, virtual chronic conditions care and preventive
healthcare through conversational AI. Ms. Dai has been honored on
Forbes' "World's Most Powerful Women" list and was named an EY
Entrepreneur of the Year. She is recognized for her visionary work
at Marvell and in technology advocacy for women and minorities. Ms.
Dai holds a Bachelor of Science degree in Computer Science from the
University of California, Berkeley.
Ms. Estradas currently serves as the Chief Executive Officer of
Arroyo Vista Family Health Center, a non-profit network of
community health centers serving Greater
Northeast Los Angeles since 1981. Under Ms. Estradas'
leadership, Arroyo Vista has grown from a small storefront clinic
to a healthcare delivery network of four health centers and a
mobile medical clinic serving the healthcare needs of
medically underserved families within its local communities as
a Federally Qualified Health Center (FQHC). Ms. Estradas also
currently serves as a City Health Commissioner in Los Angeles. Her experience includes hospital
and community public health nursing at UCLA, the Eastern Los Angeles Regional Center for
the Developmentally Disabled, the State of California Department of
Health Services – Rural Health Farmworker Division, and Arroyo
Vista Family Health Center. Ms. Estradas has a Bachelor of Science
degree in Nursing as well as a master's degree in Public Health,
both from UCLA.
Brandon Sim, Co-Chief Executive
Officer of ApolloMed, stated, "We are very excited to welcome Weili
and Lorraine to the ApolloMed Board. We believe Weili's
extraordinary leadership and years of experience as an executive,
venture capitalist, and board member in the technology and digital
health industries will be a valuable asset to ApolloMed as we
continue improving our technology platform and AI capabilities
while executing on our nationwide growth strategy. Lorraine brings
decades of knowledge and leadership within the Los Angeles healthcare community, as well as a
proven ability to grow a community health organization and FQHC
that is dedicated to providing the highest quality of
compassionate, culturally sensitive care to a diverse community. We
are thrilled to have tapped these two industry leaders as directors
for our Board and look forward to benefitting from their guidance
as we move forward with our plans to expand our model of empowering
providers within our existing markets and beyond in the successful
delivery of value-based care."
About Apollo Medical Holdings, Inc.
ApolloMed is a
leading physician-centric, technology-powered, risk-bearing
healthcare company. Leveraging its proprietary end-to-end
technology solutions, ApolloMed operates an integrated healthcare
delivery platform that enables providers to successfully
participate in value-based care arrangements, thus empowering them
to deliver high quality care to patients in a cost-effective
manner.
Headquartered in Alhambra,
California, ApolloMed's subsidiaries and affiliates include
management services organizations (MSOs), affiliated independent
practice associations (IPAs), and a Next Generation Accountable
Care Organization (NGACO). For more information, please visit
www.apollomed.net.
Forward Looking Statements
This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, such as statements
about the Company's operational focus, strategic growth and
expansion plans, and future collaboration opportunities.
Forward-looking statements reflect current views with respect to
future events and financial performance and therefore cannot be
guaranteed. Such statements are based on the current expectations
and certain assumptions of ApolloMed's management, and some or all
of such expectations and assumptions may not materialize or may
vary significantly from actual results. Actual results may also
vary materially from forward-looking statements due to risks,
uncertainties and other factors, known and unknown, including the
risk factors described from time to time in ApolloMed's reports
filed with the Securities and Exchange Commission, including,
without limitation, the risk factors contained in ApolloMed's
Annual Report on Form 10-K for the year ended December 31, 2020, and any subsequent Quarterly
Reports on Form 10-Q.
FOR MORE INFORMATION, PLEASE CONTACT:
Investor
Relations
(626) 943-6491
investors@apollomed.net
Carolyne Sohn, The Equity
Group
(415) 568-2255
csohn@equityny.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/apollo-medical-holdings-inc-appoints-weili-dai-and-j-lorraine-estradas-to-its-board-of-directors-301448023.html
SOURCE Apollo Medical Holdings, Inc.